Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Mariana E. Witgert Bradshaw Image

      Mariana E. Witgert Bradshaw, Ph.D., ABPP

      Department of Neuro-Oncology, Division of Cancer Medicine

      About Dr. Mariana E. Witgert Bradshaw

      Mariana Bradshaw, PhD, is a board certified clinical neuropsychologist and associate professor in the Section of Neuropsychology, Department of Neuro-Oncology. She earned her PhD in clinical psychology from the University of Houston with a specialty in neuropsychology. After completing a two-year neuropsychology fellowship at MD Anderson Cancer Center, she joined the faculty in 2008. She is dedicated to patient care, providing comprehensive assessments of cancer patients who experience cognitive changes secondary to cancer, cancer treatment, and/or unrelated neurological processes, as well as mood disturbances. She also serves as the section’s Director of Training.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Professor, Neuro-Oncology, Section of Neuropsychology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2006University of Houston, Houston, Texas, US, Clinical Psychology, Ph.D
      2003University of Houston, Houston, Texas, US, Psychology, MA
      2001The University of Rochester, Rochester, New York, US, Psychology, BA

      Postgraduate Training

      2006-2008Clinical Fellowship, Neuropsychology, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2005-2006Clinical Internship, Clinical Psychology/Neuropsychology, University of Arizona Health Sciences Center, Tucson, Arizona

      Licenses & Certifications

      2011American Board of Professional Psychology, Board Certified in Clinical Neuropsychology
      2008Texas State Board of Examiners of Psychologists

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Neuro-Oncology, Section of Neuropsychology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2023

      Assistant Professor, Neuro-Oncology, Section of Neuropsychology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2017

      Instructor, Neuro-Oncology, Section of Neuropsychology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2010

      Administrative Appointments/Responsibilities

      Director of Neuropsychology Training, Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - Present

      Extramural Institutional Committee Activities

      Subject Matter Expert, Epic Efficiency Sprint, The University of Texas MD Anderson Cancer Center, 2020 - 2020

      Member, Neuro-Oncology Chair Advisory Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2019

      Member, Professional Advisory Committee (Clinical Pastoral Education Program), The University of Texas MD Anderson Cancer Center, 2017 - 2020

      Member, MDACC Psychologists Credentialing Committee, The University of Texas MD Anderson Cancer Center, 2017 - Present

      Chair, Education Committee for Health Professionals, The University of Texas MD Anderson Cancer Center, 2016 - 2018

      Member, Brain and Spine Patient Care Team Meeting, The University of Texas MD Anderson Cancer Center, 2016 - Present

      Chair-Elect, Education Committee for Health Professionals, The University of Texas MD Anderson Cancer Center, 2015 - 2016

      Member, Education Committee for Health Professionals, The University of Texas MD Anderson Cancer Center, 2015 - Present

      Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2011 - 2012

      Member, Psychosocial Behavioral & Health Services Research Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2012

      Honors & Awards

      2024 - 2027Multi-Year Appointment (Re-Award), UT MD Anderson Cancer Center
      2021 - 2024Multi-Year Appointment, UT MD Anderson Cancer Center
      2018 - PresentNominee, Gerald P. Bodey Award for Excellence in Education
      2018Outstanding Program Director Award, Clinical Health Professionals
      2017 - PresentNominee, Gerald P. Bodey Award for Excellence in Education
      2016 - 2018Nominee, Gerald P. Bodey Award for Excellence in Education

      Professional Memberships

      American Academy of Clinical Neuropsychology

      2011 - Present

      National Academy of Neuropsychology

      2011 - 2012

      Society for Neuro-Oncology

      2009 - Present

      Houston Neuropsychological Society

      2008 - Present

      International Neuropsychological Society

      2008 - Present

      Selected Presentations & Talks

      National Presentations

      1. 2021. Neuropsychological Services in Cancer Care: Critical Considerations from Pediatrics to Adulthood. Invited. Presented at the MD Anderson Division of Pediatrics Grand Rounds. Houston, TX, US.
      2. 2015. Palliative Care and Rehabilitation Medicine. Invited. The University of Texas M.D. Anderson Cancer Center. Houston, TX, US.

      International Presentations

      1. 2022. Models of Neuropsychological Assessment in Pediatric and Adult Oncology Settings. Invited. INS SIG 2022 Webinar Series, US.

      Formal Peers

      1. 2020. Invited Speaker, Neuropsychological Practice in Oncology. Invited. Houston, TX, US.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Chibawanye I E, Silva E, Noll K, Bradshaw ME, Connelly K, Liu H, Tummala R, Ferson D, Lang FF, Kumar VA. Language mapping during awake brain surgery in a deaf patient with a brain tumor: illustrative case. J Neurosurg Case Lessons 9(18):CASE2597, 2025. e-Pub 2025.
      2. Bander, ED, Noll, KR, de Almeida, R, Seaman, S, Banu, MA, Clark, VE, Suki, D, Wefel, JS, Bradshaw, ME, Ferguson, SD, Weinberg, J, Lang Jr, FF, Prabhu, SS. Relationships Between Surgical Approach, Tumor Classification Scheme, and Early Neurocognitive Outcome After Awake Craniotomy for Resection of Insular Glioma. Operative Neurosurgery Publish Ahead of Print:1-10, 2025. e-Pub 2025. PMID: 40985652.
      3. Estevis E, Noll KR, Bradshaw ME, Wefel JS. Driver safety in patients with primary brain tumors. Neurooncol Pract 6(6):490-498, 2019. e-Pub 2019. PMID: 31832220.
      4. Noll KR, Bradshaw ME, Weinberg JS, Wefel JS. Neurocognitive functioning is associated with functional independence in newly diagnosed patients with temporal lobe glioma. Neurooncol Pract 5(3):184-193, 2018. e-Pub 2018. PMID: 30094046.
      5. Noll KR, Bradshaw ME, Weinberg JS, Wefel JS. Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma. Psychooncology 26(5):617-624, 2017. e-Pub 2017. PMID: 26677053.
      6. Wu AS, Witgert ME, Lang FF, Xiao L, Bekele BN, Meyers CA, Ferson D, Wefel JS. Neurocognitive function before and after surgery for insular gliomas. J Neurosurg 115(6):1115-25, 2011. e-Pub 2011. PMID: 21905800.
      7. Witgert M, Salamone AR, Strutt AM, Jawaid A, Massman PJ, Bradshaw M, Mosnik D, Appel SH, Schulz PE. Frontal-Lobe Mediated Behavioral Dysfunction in Amyotrophic Lateral Sclerosis. Eur J Neurol 17(1):103-10, 2010. e-Pub 2010. PMID: 19874396.
      8. Davis RN, Andresen EN, Witgert ME, Breier JI. Is basic memory structure invariant across epilepsy patient subgroups?. J Clin Exp Neuropsychol 28(6):987-997, 2006. e-Pub 2006. PMID: 16822737.
      9. Witgert ME, Wheless JW, Breier JI. Frequency of panic symptoms in psychogenic nonepileptic seizures. Epilepsy Behav 6(2):174-178, 2005. e-Pub 2005. PMID: 15710300.

      Invited Articles

      1. Wefel JS, Bradshaw ME. A Closer Look at the Effects of Cancer and Cancer Treatment on Cognitive Function. Coping with Cancer Magazine, 2019. e-Pub 2019.
      2. Noll KR, Bradshaw ME, Rexer J, Wefel JS. Neuropsychological practice in the oncology setting. Arch Clin Neuropsychol 33(3):344-353, 2018. e-Pub 2018. PMID: 29718081.
      3. Wefel JS, Bradshaw ME. Coping with the Cognitive Side Effects of Cancer. Coping Magazine, 2015. e-Pub 2015.
      4. Witgert ME, Meyers CA. Neurocognitive and Quality of Life Measures in Patients with Metastatic Brain Disease. Neurosurg Clin N Am 22(1):79-85, 2011. e-Pub 2011. PMID: 21109152.
      5. Witgert ME, Veramonti T, Hanna E. Instruments for estimation of health related quality of life in patients with skull base neoplasms. Skull Base 20(1):5-10, 2010. e-Pub 2010. PMID: 20592851.
      6. Wefel JS, Witgert ME, Meyers CA. Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev 18(2):121-131, 2008. e-Pub 2008. PMID: 18415683.

      Review Articles

      1. Sheppard, D, Noll, KR, Wefel, JS, Bradshaw, ME. Neuropsychological Evaluation for Oncology. Neurologic Clinics 42(4):875-887, 2024. e-Pub 2024. PMID: 39343481.
      2. Noll, KR, Bradshaw, ME, Sheppard, D, Wefel, JS. Perioperative Neurocognitive Function in Glioma Surgery. Current oncology reports 26(5):466-476, 2024. e-Pub 2024. PMID: 38573439.
      3. Noll KR, Bradshaw ME, Parsons MW, Dawson EL, Rexer J, Wefel JS. Monitoring of Neurocognitive Function in the Care of Patients with Brain Tumors. Curr Treat Options Neurol 21(7):33, 2019. e-Pub 2019. PMID: 31250277.

      Abstracts

      1. Bradshaw ME, Noll K, Goethe E, Srinivasan S, Prabhu S, Weinberg J, McCutcheon I, Lang F, Wefel J, Ferguson S. Neurocognitive outcomes after resection of left inferior parietal lobule gliomas. Neuro-oncol 27(suppl5):v333, 2025. e-Pub 2025.
      2. Noll KR, Bander E, Bradshaw ME, Andrade de Almeida R, Seaman S, Banu M, Clark VE, Suki D, Wefel JS, Ferguson S, Weinberg JS, Prabhu SS, Lang FF. Neurocognitive outcome following awake craniotomy for insular glioma resection: impact of surgical approach and tumor classification 26(suppl8):viii231, 2024. e-Pub 2024.
      3. Patel A, Arnold N, Awodola L, Bradshaw ME, Buchold G, Cobb C, Dougherty P, Khan S, Kleiman A, Noll KR, Mathai V, Meyer L, Morrow M, Rexer JL, Sullaway C, Wathoo C, Wefel J, Wintermark M, Ray J, Puduvalli V. The MD Anderson NeuroHealth Initiative: A Novel Standardized Program for Early Detection and Proactive Management of Neurotoxicities in Cancer Care. Neuro-Oncol 27(suppl5):v319-320, 2023. e-Pub 2023.
      4. Noll KR, Bradshaw ME, Wefel JS, Sullaway C, Thomas A, Kumar VA, Prabhu S, Liu HL. Variability in anxiety and depression symptoms after eloquent glioma resection is associated with changes in functional connectomic properties. Neuro-Oncol 25(Suppl5):v248, 2023. e-Pub 2023.
      5. Noll KR, Bradshaw ME, Chen HS, Wefel JS, Sullaway C, Thomas A, Kumar VA, Prabhu S, Liu HL. Changes in functional connectivity after surgery are associated with decline in functional independence in patients with eloquent glioma. Neuro-Oncol 25(Suppl5):v249, 2023. e-Pub 2023.
      6. Bradshaw ME, Wefel JS, Noll KR, Rao G, Ferguson SD, Tawbi H, Huse J, Johnson J, Court L, O'Brien B, Lang F, Ejezie L, Sullaway C, Thomas A, Suki D, Yeboa DN. Baseline patient-reported outcomes in an ongoing phase-III trial of pre-operative SRS vs. post-operative SRS for brain metastases. Neuro-Oncol 25(Suppl5):v213, 2023. e-Pub 2023.
      7. Eschler BD, Bradshaw ME, Wefel JS, Rexer R, Sullaway C, Noll KR. Understanding Object Dysnomia in Patients with Left Hemisphere Primary Brain Tumors. Presented at the 2023 International Cancer and Cognition Task Force Meeting, San Diego, CA, 2023.
      8. Chen H, Noll K, Prabhu S, Kumar V, Hou P, Ferguson S, Rao G, Bradshaw M, Johnson J, Schomer D, Liu HL. Functional connectome analysis of FMRI before and after brain tumor resection. Medical Physics 45(6):E368, 2018. e-Pub 2018.
      9. Wefel JS, Patwardhan SY, Bradshaw ME, Massman PJ. Validity and diagnostic accuracy of the clinical trial battery in patients with primary brain tumor. J Int Neuropsychol Soc 23(Suppl 1):p101, 2017. e-Pub 2017.
      10. Estevis E, Bradshaw ME, Wefel JS, Kesler Rexer J, Harmon CE, Rhines S, Noll K. Driver safety in patients with primary brain tumor. J Int Neuropsychol Soc 23(Suppl 1):o157, 2017. e-Pub 2017.
      11. Wefel JS, Bradshaw ME, Sullaway CM, Gilbert MR, Armstrong TS. A Brain-Plasticity Based Computerized Intervention to Treat Attention and Memory Problems in Adult Brain Tumor Survivors. Neuro-Oncology 17(Suppl 5):v149-150, 2015. e-Pub 2015.
      12. Bradshaw ME, Noll K, Ziu M, Weinberg J, Strange C, Turner C, Wefel JS. Neurocognitive functioning and functional status in patients with glioma of the temporal lobes. Neuro-Oncology 15(Suppl 3):iii92, 2013. e-Pub 2013.
      13. Turner C, Strange C, Bradshaw ME, Noll K, Wefel JS. Quality of life, mood, and neurocognitive functioning in patients with temporal lobe glioma. Neuro-Oncology 15(Suppl 3):iii96, 2013. e-Pub 2013.
      14. Witgert M, Chang E, Wefel J. Acute effects of stereotactice radiosurgery +/- whole brain radiation therapy on fatigue in patients with brain metastases. Neuro-Oncology 10(881), 2008. e-Pub 2008.
      15. Witgert M, Lang F, Suki D, Chang E, Meyers C, Wefel J. Baseline cognitive impairment in patients with single brain metastasis. Neuro-Oncology 9:571, 2007. e-Pub 2007.
      16. Witgert M, Massman PJ, Mosnik DM, Bradshaw MR, Schulz PE. Behavioral change in amyotrophic lateral sclerosis. Journal of the International Neuropsychological Society 12:134, 2006. e-Pub 2006.
      17. Witgert M, Wheless J, Breier J. Panic symptoms in nonepileptic seizures. Journal of the International Neuropsychological Society 11:57, 2005. e-Pub 2005.
      18. Witgert M, Massman P. Use of the AMNART in estimation of premorbid intelligence in Alzheimer's disease patients. Journal of the International Neuropsychological Society 10:7, 2004. e-Pub 2004.
      19. Mochache M, Bradshaw ME, Prabhu SS, Wefel JS, Noll KR. Prediction of Baseline and Postoperative Change in Verbal Episodic Memory from Learning Characteristics in Patients with Glioma Undergoing Awake Craniotomy. Presented at the 54th Annual North American Meeting of the International Neuropsychological Society.
      20. Turner C, Noll K, Strange C, Bradshaw ME, Wefel JS. Quality of life, mood, and neurocognitive functioning in patients with temporal lobe glioma. Presented at the Cancer Survivorship Research Symposium, The University of Texas M. D. Anderson Cancer Center.
      21. Noll K, Muir M, Prinsloo S, Michener H, Asman P, Kumar V, Bradshaw M, Wefel JS, Liu HL, Taylor B, Prabhu S. Influence of tractography seeding and thresholding upon relationships between surgical trauma to white matter tracts and postoperative neurocognitive outcome following resection of language-eloquent glioma. Presented at the International Cognition and Cancer Task Force.
      22. Mochache M, Bradshaw ME, Prabhu SS, Wefel JS, Noll KR. Relationships between single trial learning and baseline and preoperative change in verbal episodic memory in eloquent glioma patients. Presented at the Houston Neuropsychological Society Annual Symposium.
      23. Wefel JS, Noll KR, Sullaway CM, Bradshaw ME. Breast cancer survivors exhibit elevated rates of inattention and poor vigilance on the Conners' Continuous Performance Test - 3. 54th Annual meeting of the International Neuropsychological Society.

      Book Chapters

      1. Eschler BE, Bradshaw ME, Wefel JS. The Neuropsychology of Oncology. In: Clinical Neuropsychology: A Pocket Handbook for Assessment. 4th, 2024.
      2. Bradshaw ME. Neuropsychological Assessment of Patients with Tumors of the Skull Base. In: Comprehensive Management of Skull Base Tumors. 2nd. Thieme, 2021.
      3. Al feghali KA, Chung C, Wefel JS, Bradshaw ME. Neurocognitive Toxicity from Radiation Therapy for Brain Metastases. In: Central Nervous System Metastases. Springer, Cham, 2020.
      4. Al Feghali KA, Bradshaw ME, Chung C, Wefel JS. Neurocognitive Effects of Brain Metastases and Their Treatment. In: Central Nervous System Metastases: Diagnosis and Treatment. Springer Nature, 2020.
      5. Bradshaw ME, Wefel JS. Neuropsychological Assessment of Older Adults with a History of Cancer. In: Handbook on the Neuropsychology of Aging and Dementia. 2nd. Springer, 2018.
      6. Bradshaw ME, Wefel JS. The Neuropsychology of Oncology. In: Clinical Neuropsychology: A Pocket Handbook for Assessment. 3rd. APA, 2014.
      7. Witgert M, Wefel JS. Neuropsychological Assessment of Older Adults with a History of Cancer. In: Handbook on the Neuropsychology of Aging and Dementia. Springer, 2013.
      8. Witgert M, Wefel JS. Neurobehavioral Side Effects of Cancer and Cancer Therapy. In: MD Anderson Manual of Psychosocial Oncology. McGraw-Hill, 2011.
      9. Witgert ME, Meyers CA. Neurocognitive function and quality of life measures in patients with metastatic brain tumors. In: Neurosurgery Clinics of North America: Management of Brain Metastases. W. B. Saunders Company, 2011.
      10. Witgert M, Veramonti T. Neurocognitive assessment of patients with tumors of the skull base. In: Comprehensive Management of Tumors of the Skull Base. Informa Healthcare, 2009.
      11. Bradshaw ME, Noll KR, Wefel JS. The Neuropsychology of Adult Cancers. In: Textbook of Clinical Neuropsychology. 3rd. Taylor & Francis.
      12. Bradshaw ME, Noll, KR, Wefel JS. Neurocognitive Function and Quality of Life. In: Neuro-Oncology: The Essentials. 4th. Thieme.
      13. Bradshaw ME, Wefel JS. Cancer and Cognition. In: Neuropsychology of Alzheimer's Disease and Other Dementias. 2nd. Oxford University Press; in press.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top